Eunice Alvazzi | Global Head, Hematology, Nephrology, Transplant & Neurology, Access & Pricing
Alexion – AstraZeneca Rare Disease

Eunice Alvazzi is a dynamic and results-driven leader with extensive experience in market access and pricing.  She currently serving as Global Head of Complement, Access & Pricing focusing on Hematology, Nephrology, Transplant & Neurology therapeutic areas at Alexion – AstraZeneca Rare Disease. With hands-on expertise in global pricing and reimbursement across both specialty and rare disease areas, Eunice previously held the role of Head of Global Pricing at Shire, where she was instrumental in developing and implementing pricing strategies that enabled patient access worldwide.

Throughout her career, Eunice has demonstrated a deep commitment to improving healthcare outcomes and ensuring that innovative treatments are accessible to those in need. Her expertise lies in navigating complex healthcare systems, forging strategic partnerships, and advocating for cross-functional solutions that support patient access to advanced therapies.

At the World EPA Congress 2026, Eunice will share her insights on the evolving landscape of pricing and access, particularly in the context of rare diseases.